Onyx Pharmaceuticals News
Most Popular Onyx Pharmaceuticals Story
NICE says no to Nexavar in liver cancer
It's a good news-bad news day for Bayer and Onyx Pharmaceuticals' Nexavar drug. While Onyx CEO Anthony Coles touted soon-to-be released data on Nexavar use against breast cancer, the U.K.'s National Read more...
Latest Headlines
- October 12, 2011
- September 10, 2009
- April 27, 2009
- April 14, 2009
- December 11, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
